ad image

Company Info

Piramal Pharma Solutions

Piramal Pharma Solutions

CDMO / Excipients / Intermediates

Overview

Piramal Pharma Solutions is the contract development and manufacturing arm of Piramal Healthcare, a part of Piramal Enterprises Limited. Piramal Pharma Solutions provides a comprehensive range of services across all phases of the drug life cycle, including drug discovery and development, manufacturing and packaging of clinical trial supplies, and delivering commercial volumes of APIs and finished dosage products. The company provides flexibility and scalability of operations and has invested in a network of contract development and manufacturing facilities located in North America, Europe and Asia.
Piramal Pharma Solutions
Contributions
11 Contributions1 / 1
Piramal Pharma Solutions
In Vitro Biology

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Piramal Pharma Solutions

PR-M10-23-04Oct 17, 2023
Piramal Pharma Solutions
New Facility

Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site

Piramal Pharma Solutions

PR-M07-22-04Jul 13, 2022
Piramal Pharma Solutions
In Vitro Biology

Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Piramal Pharma Solutions

PR-M01-22-03Jan 04, 2022
Piramal Pharma Solutions

Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

Piramal Pharma Solutions

PR-M03-21-008Mar 31, 2021
Piramal Pharma Solutions
M&A

Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

Piramal Pharma Solutions

PR-M06-20-NI-033Jun 25, 2020
Piramal Pharma Solutions
Collaboration

Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment

Piramal Pharma Solutions

PR-M12-19-NI-005Dec 05, 2019
True Integration is Integral to Providing One-Stop-Shop CDMO Services
Integration

True Integration is Integral to Providing One-Stop-Shop CDMO Services

Stuart E. Needleman

Piramal Pharma Solutions

PAP-Q3-19-CL-022Oct 28, 2019
Rapid Growth in the ADC Market Drives Strategic Partnership Interest
Antibody-Drug Conjugates

Rapid Growth in the ADC Market Drives Strategic Partnership Interest

Allan Davidson

Piramal Pharma Solutions

PAP-Q1-2019-CL-031Mar 12, 2019
Piramal Pharma Solutions
Award

Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'

Piramal Pharma Solutions

PR-M03-18-NI-099Mar 28, 2018
ADCs: The Future of Biologic Drugs
Biologics

ADCs: The Future of Biologic Drugs

Guy Tiene; Gabriel Haering, Ph.D.; Thomas Rohrer; Mark Wright, Ph.D.; Scott Miller, Ph.D.; Jean Blehaut

Nice Insight

PAP-Q04-17-VP-001Oct 26, 2017
Q: What will be the Impact of the Requirements that Drug Manufacturers Gain a Similar Level of Supply Chain Understanding for Excipients as they Must Have for APIs?

Q: What will be the Impact of the Requirements that Drug Manufacturers Gain a Similar Level of Supply Chain Understanding for Excipients as they Must Have for APIs?

William van den Bremer; Ramesh Subramanian, Ph.D.; Dirk Hair; Patricia Rafidison

DFE Pharma

PAP-Q1-17-RT-005Mar 08, 2017
1 / 1